InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: Carboat post# 199116

Wednesday, 12/10/2014 9:45:55 AM

Wednesday, December 10, 2014 9:45:55 AM

Post# of 346155

I am sure a bill for services rendered is forthcoming from the consultant.



Carboat, you must think big and think Bavi.

Peregrine is not venturing into the business of rolling the dice and gambling on expansion of manufacturing facilities and "hope" there PS Targeting pipeline and 3rd party clients will be able to help them make use of the extra expenses of this manufacturing facility.

They need it now and if we are officially hearing about it now.... its up and ready "Soon".

I moved on from this manufacturing story months ago, after the 3 linkedin profiles sort of confirmed all this (especially after all 3 linkedin profiles were edited within 24 hours). Next, we have much bigger biotech backers from the Middle East that likely need to place some big oil money somewhere. Directly or indirectly.... Peregrine Pharmaceuticals would seem to be the ultimate benefactor.

Now back to piecing together some clues.... may need Shaggy and the Mystery Machine for some of it







"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News